Dexamethasone EP Enpurite H

Non Chimik:

2-((8S,10S,13S,14S,16R,17R)-17-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,10,12,13,14,15,16 ,17-decahydro-3H-cyclopenta[a]phenantren-17-yl)-2-oxoethyl acetate

Kòd SMILES:

[H][C@@]12C[C@@H](C)[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC=C3 [C@@]2([H])CCC4=CC(=O)C=C[C@]34C

Kòd InChi:

InChI=1S/C24H30O5/c1-14-11-20-18-6-5-16-12-17(26)7-9-22(16,3)19(18)8-10-23(20, 4)24(14,28)21(27)13-29-15(2)25/h7-9,12,14,18,20,28H,5-6,10-11,13H2,1-4H3/ t14-,18-,20+,22+,23+,24+/m1/s1

InChi kle:

AAPZMQVULRVUEU-PYAFTSMNSA-N

Mot:

10106-41-9；CAS:10106-41-9；CAS:10106-41-9；Vamorolone acetate, Vamorolone, VBP-15, VBP15, VBP 15

Solibilite: 

Depo:Sèk, nwa ak nan 0 -4 C pou kout tèm (jou a semèn) oswa -20 C pou tèm long (mwa a ane).

Deskripsyon:

Vamorolone, konnen tou kòm VBP-15, se yon konpoze anti-enflamatwa yo itilize nan tretman distwofi miskilè.

Sib: